Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-028531
Filing Date
2010-05-18
Accepted
2010-05-17 17:31:43
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v185527_10k.htm 10-K 3745802
2 GRAPHIC chart.jpg GRAPHIC 56449
3 GRAPHIC kempseysig.jpg GRAPHIC 2624
4 GRAPHIC pg11.jpg GRAPHIC 26107
5 GRAPHIC pg12.jpg GRAPHIC 42913
6 GRAPHIC pg13.jpg GRAPHIC 44883
7 GRAPHIC pg14.jpg GRAPHIC 53190
8 GRAPHIC pg61.jpg GRAPHIC 100078
9 GRAPHIC pg88.jpg GRAPHIC 75657
10 v185527_ex31.htm EX-31 11605
11 v185527_ex32.htm EX-32 9921
  Complete submission text file 0001144204-10-028531.txt   4323711
Mailing Address 4TH TAIBEI MINGJU, 6 TAIBEI ROAD, WUHAN, HUBEI PROVINCE, F4 430015
Business Address 4TH TAIBEI MINGJU, 6 TAIBEI ROAD, WUHAN, HUBEI PROVINCE, F4 430015 86-27-8549 4916
Benda Pharmaceutical, Inc. (Filer) CIK: 0000705868 (see all company filings)

EIN.: 411419457 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16397 | Film No.: 10840333
SIC: 2834 Pharmaceutical Preparations